[pubmed] A series of patients with refractory myasthenia gravis
Posté : 11 nov. 2020 12:00
Neurologia. 2020 Nov 7:S0213-4853(20)30293-0. doi: 10.1016/j.nrl.2020.08.016. Online ahead of print.
ABSTRACT
INTRODUCTION: Advances in the treatment of myasthenia gravis (MG) have improved quality of life and prognosis for the majority of patients. However, 10%-20% of patients present refractory MG, with frequent relapses and significant functional limitations.
PATIENTS AND METHODS: Patients with refractory MG were selected from a cohort of patients diagnosed with MG between January 2008 and June 2019. Refractory MG was defined as lack of response to treatment with prednisone and at least 2 immunosuppressants, inability to withdraw treatment without relapse in the last 12 months, or intolerance to treatment with severe adverse reactions.
RESULTS: We identified 84 patients with MG, 11 of whom (13%) met criteria for refractory MG. Mean (standard deviation) age was 47 (18) years; 64% of patients with refractory MG had early-onset generalised myasthenia (as compared to 22% in the group of patients with MG; P
Source: https://pubmed.ncbi.nlm.nih.gov/3317268 ... 6&v=2.13.0